Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.21 - $0.32 $394,607 - $601,306
1,879,083 Added 400.48%
2,348,287 $505,000
Q2 2022

Aug 09, 2022

BUY
$0.26 - $0.64 $12,829 - $31,581
49,346 Added 11.75%
469,204 $122,000
Q1 2022

May 11, 2022

SELL
$0.52 - $1.0 $39,481 - $75,925
-75,925 Reduced 15.31%
419,858 $252,000
Q4 2021

Feb 14, 2022

BUY
$0.85 - $1.33 $409,423 - $640,627
481,675 Added 3414.2%
495,783 $485,000
Q3 2021

Nov 12, 2021

BUY
$1.03 - $1.41 $14,531 - $19,892
14,108 New
14,108 $18,000
Q1 2021

May 10, 2021

SELL
$0.84 - $2.16 $18,984 - $48,816
-22,600 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$0.65 - $1.11 $14,690 - $25,086
22,600 New
22,600 $19,000

Others Institutions Holding NMTR

About 9 METERS BIOPHARMA, INC.


  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.